Safety and efficacy of nivolumab plus ipilimumab in patients with advanced non-clear cell renal cell carcinoma: results from the phase 3b/4 CheckMate 920 trial

Scott S. Tykodi, Lucio N. Gordan, Robert S. Alter, Edward Arrowsmith, Michael R. Harrison, Ivor Percent, Rakesh Singal, Peter Van Veldhuizen, Daniel J. George, Thomas Hutson, Joshua Zhang, Jesus Zoco, Jennifer L. Johansen, Arash Rezazadeh Kalebasty

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'Safety and efficacy of nivolumab plus ipilimumab in patients with advanced non-clear cell renal cell carcinoma: results from the phase 3b/4 CheckMate 920 trial'. Together they form a unique fingerprint.

Medicine & Life Sciences